TuHURA Biosciences, Inc.
HURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498382
No open-market purchases or sales by TuHURA Biosciences, Inc. insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding TuHURA Biosciences, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 13 | 17 | +4 |
| Shares | 495.7K | 819.1K | +323.3K (+65.2%) |
| Value | $51.0K | $219.0K | +$168.0K (+329.5%) |
New holders (7)
Institutions that held TuHURA Biosciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 74,115 | $20.0K | 0.00% |
| Level Four Advisory Services, LLC | 44,642 | $12.1K | 0.00% |
| Baader Bank INC | 42,670 | $9.39K | 0.00% |
| Clear Creek Financial Management, LLC | 27,500 | $7.43K | 0.00% |
| Integrated Wealth Concepts LLC | 22,000 | $5.94K | 0.00% |
| Bank of America Corp | 2,268 | $612 | 0.00% |
| FMR LLC | 20 | $5 | 0.00% |
Sold out (3)
Institutions that held TuHURA Biosciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| HRT Financial LP | 81,604 | $8.00K |
| Nantahala Capital Management, LLC | 12,763 | $1.28K |
| Wells Fargo & Company | 26 | $3 |